Metazosin
From Wikipedia, the free encyclopedia
Names | |
---|---|
IUPAC name
1-[4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-2-methoxypropan-1-one
|
|
Other names
Kenosin
|
|
Identifiers | |
3D model (Jmol) | Interactive image |
ChemSpider | 84417 |
PubChem | 93514 |
|
|
|
|
Properties | |
C18H25N5O4 | |
Molar mass | 375.43 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Metazosin is an antihypertensive alpha-adrenergic antagonist.[1][2]
References[edit]
- ^ Trcka, V; König, J; Mácová, S; Smíd, M; Helfert, I; Votavová, M; Remesová, J; Nezádalová, E (1990). "Pharmacology of a new antihypertensive agent, metazosin (Kenosin)". Ceskoslovenska farmacie. 39 (6): 266–74. PMID 1981860.
- ^ Lapka, R; Rejholec, V; Sechser, T; Peterková, M; Smíd, M (1989). "Interspecies pharmacokinetic scaling of metazosin, a novel alpha-adrenergic antagonist". Biopharmaceutics & drug disposition. 10 (6): 581–9. PMID 2575403.
This article about an organic compound is a stub. You can help Wikipedia by expanding it. |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |